Cold and hot fibrosis define clinically distinct cardiac pathologies

Fibrosis remains a major unmet medical need. Simplifying principles are needed to better understand fibrosis and to yield new therapeutic approaches. Fibrosis is driven by myofibroblasts that interact with macrophages. A mathematical cell-circuit model predicts two types of fibrosis: hot fibrosis driven by macrophages and myofibroblasts and cold fibrosis driven by myofibroblasts alone. Testing these concepts in cardiac fibrosis resulting from myocardial infarction (MI) and heart failure (HF), we revealed that acute MI leads to cold fibrosis whereas chronic injury (HF) leads to hot fibrosis. MI-driven cold fibrosis is conserved in pigs and humans. We computationally identified a vulnerability of cold fibrosis: the myofibroblast autocrine growth factor loop. Inhibiting this loop by targeting TIMP1 with neutralizing antibodies reduced myofibroblast proliferation and fibrosis post-MI in mice. Our study demonstrates the utility of the concepts of hot and cold fibrosis and the feasibility of a circuit-to-target approach to pinpoint a treatment strategy that reduces fibrosis. A record of this paper's transparent peer review process is included in the supplemental information.

Authors

Institutions

Publication Details

Journal
Cell Systems
Published
2025-02-18
DOI
https://doi.org/10.1016/j.cels.2025.101198
Citations
17
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
23.60

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cold and hot fibrosis define clinically distinct cardiac pathologies

Ofra Golani, Julio Sáez-Rodríguez, Shoval Miyara, Michael Gershovits et al.
17 citations
Cell Systems
Cardiac Fibrosis and Remodeling
23.60
article

Cold and hot fibrosis define clinically distinct cardiac pathologies

Ofra Golani, Julio Sáez-Rodríguez, Shoval Miyara, Michael Gershovits, Miri Adler, Tatjana Dorn, Tali Shalit, Daria Lendengolts, Yalin Divinsky, Ricardo O. Ramirez Flores, Elly M. Tanaka, Jingkui Wang, Ruslan M. Medzhitov, Rachel Sarig, Zachary Petrover, David Kain, Christian Kupatt, Alessandra Moretti, Eldad Tzahor, Jacob Elkahal, Kfir Baruch Umansky, Achim Krüger, Danielle M. Kimchi, Elad Bassat, Alexander Genzelinakh, Avi Mayo, Eviatar Weizman, Avraham Shakked, Daniel Häußler, Lingling Zhang, Uri Alon, Andrea Baehr, Hanna Bueno-Levy
article en
17 citations

Abstract

Fibrosis remains a major unmet medical need. Simplifying principles are needed to better understand fibrosis and to yield new therapeutic approaches. Fibrosis is driven by myofibroblasts that interact with macrophages. A mathematical cell-circuit model predicts two types of fibrosis: hot fibrosis driven by macrophages and myofibroblasts and cold fibrosis driven by myofibroblasts alone. Testing these concepts in cardiac fibrosis resulting from myocardial infarction (MI) and heart failure (HF), we revealed that acute MI leads to cold fibrosis whereas chronic injury (HF) leads to hot fibrosis. MI-driven cold fibrosis is conserved in pigs and humans. We computationally identified a vulnerability of cold fibrosis: the myofibroblast autocrine growth factor loop. Inhibiting this loop by targeting TIMP1 with neutralizing antibodies reduced myofibroblast proliferation and fibrosis post-MI in mice. Our study demonstrates the utility of the concepts of hot and cold fibrosis and the feasibility of a circuit-to-target approach to pinpoint a treatment strategy that reduces fibrosis. A record of this paper's transparent peer review process is included in the supplemental information.

Cell SystemsVol. 16(3)
Institute of Molecular Biotechnology (AT), European Bioinformatics Institute (GB), Howard Hughes Medical Institute (US), Research Institute of Molecular Pathology (AT), Heidelberg University (DE), University Hospital Heidelberg (DE), TUM Klinikum (DE), Yale University (US), German Centre for Cardiovascular Research (DE), Vienna Biocenter (AT), Weizmann Institute of Science (IL), Technical University of Munich (DE)
Cancer Research UK, Deutsche Forschungsgemeinschaft, Israel Science Foundation, FP7 Coordination of Research Activities, H2020 European Research Council
Openalex Percentile: Top 0%
Cardiac Fibrosis and Remodeling
23.60
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.